Hessekiel Jeffrey
Cytokinetics, Incorporated - Common Stock ยท Chief Legal & Admin Officer
Hessekiel Jeffrey is listed in public filings as officer: Chief Legal & Admin Officer. This Hessekiel Jeffrey insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cytokinetics, Incorporated - Common Stock (CYTK), and Exelixis Inc (EXEL). Investors use Hessekiel Jeffrey's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.4M22.8k shares | Grant / ExerciseMar 15, 2026 | $1.4M22.8k shares | $60.06 | -- | |
| $500k8.3k shares | Grant / ExerciseMar 15, 2026 | $500.0K8.3k shares | $60.06 | -- | |
| --107.9k shares | Grant / ExerciseMar 15, 2026 | Disclosure amount unavailable20.6k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --87.3k shares | Grant / ExerciseNov 14, 2025 | Disclosure amount unavailable87.3k shares | -- | -- | |
| $32M718.4k shares | Grant / ExerciseMay 15, 2025 | $1.5M34k shares | $44.65 | -- | |
| $32M693.4k shares | SellMay 15, 2025 | $1.2M25k shares | $46.18 | -- | |
| --751.7k shares | Grant / ExerciseMar 31, 2025 | Disclosure amount unavailable154.1k shares | -- | -- | |
| --597.6k shares | Grant / ExerciseFeb 26, 2025 | Disclosure amount unavailable52.2k shares | -- | -- | |
| $19M545.4k shares | Grant / ExerciseFeb 15, 2025 | $634.7K18.1k shares | $35.00 | -- | |
| $21M563.6k shares | Grant / ExerciseJan 16, 2025 | $979.8K26.3k shares | $37.27 | -- | |
| --589.8k shares | Grant / ExerciseJan 16, 2025 | Disclosure amount unavailable118.8k shares | -- | -- | |
| $18M486.1k shares | SellNov 29, 2024 | $2.2M60k shares | $36.67 | -- | |
| --471.1k shares | Grant / ExerciseNov 29, 2024 | Disclosure amount unavailable15k shares | -- | -- | |
| $20M546.1k shares | Grant / ExerciseNov 27, 2024 | $3.6M98.9k shares | $35.93 | -- | |
| $0129.3k shares | Grant / ExerciseNov 27, 2024 | $2.4M129.3k shares | $18.80 | -- | |
| $18M515.7k shares | Grant / ExerciseNov 15, 2024 | $514.3K14.7k shares | $35.05 | -- | |
| $18M530.3k shares | SellNov 1, 2024 | $1.7M50k shares | $34.13 | -- | |
| $16M580.3k shares | SellOct 28, 2024 | $709.8K25k shares | $28.39 | -- | |
| $16M605.3k shares | SellSep 23, 2024 | $659.5K25k shares | $26.38 | -- | |
| $16M630.3k shares | SellAug 26, 2024 | $515.8K20k shares | $25.79 | -- | |
| $020k shares | Grant / ExerciseAug 26, 2024 | $488.2K20k shares | $24.41 | -- | |
| $16M630.3k shares | SellAug 7, 2024 | $2.1M80k shares | $25.97 | -- | |
| $488k20k shares | Grant / ExerciseAug 7, 2024 | $2.0M80k shares | $24.41 | -- |